Showing results (761-770 of 789) with videos related to

Sort By:
Pageof 79
International Journal of Cancer|February 20, 2026
Patient- and caregiver-reported barriers to radiotherapy for cancer in sub-Saharan Africa-A survey of population-based registriesEric Sven Kroeber, Tamara König, Ole Stöter, et al.
BMC Cancer|June 23, 2019
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM studyMarkus Wallwiener, Naiba Nabieva, Manuel Feisst, et al.
Breast Cancer Research and Treatment|April 2, 2026
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trialManuel Hörner, Lara M Tretschock, Nelson John, et al.
Journal of Clinical Medicine|March 25, 2022
The Future of Adhesion Prophylaxis Trials in Abdominal Surgery: An Expert Global ConsensusRudy Leon De Wilde, Rajesh Devassy, Richard P G Ten Broek, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2017
The immunopeptidomic landscape of ovarian carcinomasHeiko Schuster, Janet K Peper, Hans-Christian Bösmüller, et al.
NPJ Breast Cancer|April 11, 2026
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registryManuel Hörner, Andreas Hartkopf, Nelson John, et al.
Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.
Neuro-Oncology Practice|May 13, 2024
App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE)Lorenz Dörner, Lucia Grosse, Felix Stange, et al.
Annals of Surgical Oncology|November 10, 2023
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New ConceptAndré Pfob, Lie Cai, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Pageof 79